Bulletin
Investor Alert

Market Pulse Archives

Jan. 3, 2022, 8:12 a.m. EST

Immix Biopharma's stock rockets after pediatric cancer treatment granted RPD by the FDA

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Immix Biopharma Inc. (IMMX)
  • X
    iShares Biotechnology ETF (IBB)
  • X
    E-Mini S&P 500 Future Continuous Contract (ES00)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Immix Biopharma Inc. /zigman2/quotes/230750752/composite IMMX +12.50% rocketed 66.0% in premarket trading Monday, after the biopharmaceutical company said its IMX-110 was granted Rare Pediatric Disease (RPD) designation by the Food and Drug Administration for the threatment of pediatric cancer. The company said IMX-110 is current being evaluated in a Phase 1b/2a clinical trial. The company said if a New Drug Application (NDA) is approved, the company could be eligible to receiver a Priority Review Voucher (PRV) that can be redeemed to obtain priority review for any subsequent marketing application. "We are pleased by FDA's acknowledgment of the urgent need for a safe and effective treatment for children with this devastating disease," said Immix Chief Executive Ilya Rachman. "We are encouraged by our Phase 1b/2a clinical data in soft tissue sarcoma." The rally in Immix's stock, which went public on Dec. 16, comes as the iShares Biotechnology ETF /zigman2/quotes/206189322/composite IBB +0.90% was little changed ahead of the open while futures /zigman2/quotes/209948968/delayed ES00 -0.09% for the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.99% gained 0.6%.

/zigman2/quotes/230750752/composite
US : U.S.: Nasdaq
$ 2.97
+0.33 +12.50%
Volume: 2.87M
May 26, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$36.66 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/206189322/composite
US : U.S.: Nasdaq
$ 115.80
+1.03 +0.90%
Volume: 2.10M
May 26, 2022 4:15p
loading...
/zigman2/quotes/209948968/delayed
US : U.S.: CME
$ 4,052.00
-3.75 -0.09%
Volume: 39,317
May 26, 2022 11:15p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,057.84
+79.11 +1.99%
Volume: 2.40B
May 26, 2022 5:42p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.